DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aplisol (Tuberculin) - Injection Site Erythema - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Injection Site Erythema (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Aplisol (Tuberculin) where reactions include injection site erythema. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Aplisol side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-10

Patient: male, weighing 99.8 kg (219.5 pounds)

Reactions: Injection Site Erythema, Injection Site Swelling

Drug(s) suspected as cause:
Aplisol

Other drugs received by patient: Aplisol



Possible Aplisol side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-05

Patient: female

Reactions: Injection Site Erythema, Injection Site Pruritus

Drug(s) suspected as cause:
Aplisol

Aplisol
    Dosage: 0.1 ml, single, intradermal
    Indication: Tuberculin Test
    Start date: 2011-01-01
    End date: 2011-01-01



Possible Aplisol side effects in 25 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-05

Patient: 25 year old female

Reactions: Injection Site Erythema, Hypersensitivity, Similar Reaction ON Previous Exposure To Drug

Drug(s) suspected as cause:
Aplisol
    Dosage: 0.1 ml, single, intradermal
    Indication: Tuberculosis
    Start date: 2011-06-24
    End date: 2011-06-24

Aplisol
    Dosage: 0.1 ml, single, intradermal
    Indication: Tuberculosis
    Start date: 2011-09-20
    End date: 2011-09-20

Aplisol
    Dosage: 0.1 ml, single, intradermal
    Indication: Tuberculosis
    Start date: 2011-07-18
    End date: 2011-07-18

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017